SS-31 (Elamipretide) 10mg
Mitochondrial cardiolipin stabiliser — cardiac and organ protection
BioBlend Pharma Grade3ml vialCardiolipin Guardian
SS-31 (Elamipretide) 10mg
Mitochondrial cardiolipin stabiliser — cardiac and organ protection
Contact for pricing
Administration
Injectable
First Results
4–8 weeks
Cycle Length
8–12 weeks
Clinical Uses
- Cardiac mitochondrial support
- Age-related organ fatigue
- Cellular stress resilience
- Renal and hepatic protection
Key Benefits
- Stabilises inner mitochondrial membrane cardiolipin
- Reduces oxidative stress in heart and organs
- Supports ATP production efficiency
- Preserves cellular function under stress
How It Works — Mechanism of Action
Elamipretide selectively concentrates near cardiolipin, restoring cristae structure and electron-transport-chain supercomplex assembly for efficient ATP synthesis.
Your SS-31 (Elamipretide) 10mg protocol, wherever you are
A pre-filled, easy-to-carry pen for self-administration at home, the gym or the office. Dispensed safely after physician approval and delivered cold-chain to you.
Dosage Protocol
1–4 mg subcutaneous daily. Cycle 8–12 weeks under physician review.
When to Expect Results
Weeks 4–8: improved energy and stamina. Weeks 8–12: biomarker improvement.
Side Effects
Generally well tolerated. Rare: mild injection-site redness. Contact your physician for any unusual symptom.
Contraindications
Active cancer, pregnancy, hypersensitivity to peptide components. Always review with your physician.
Best Stacked With
Consult your physician for synergistic stacking options matched to your goal.
Understanding Your Body’s Language
Ready to start your SS-31 (Elamipretide) 10mg protocol?
All peptide protocols require a physician consultation and blood work. Our licensed UAE team will craft a personalised plan for you.
Book a consultation